Authors
Loading...
Randomized trial assesses angiomotin-like 1's impact on actin remodeling in endothelial cells, suggesting implications for angiogenesis-driven diseases.
Gagné et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: